Now showing items 1-8 of 8

    • “Blame it on the Comorbidities”: A 5-Year Follow-Up of 53 Chronic Dialysis-Dependent Patients Who Underwent Cardiac Surgery 

      Deutsch O., Rippinger N., Spiliopoulos K., Eichinger W., Gansera B. (2016)
      Objectives This study evaluates midterm survival rates and risk factors for mortality of chronic dialysis-dependent patients undergoing cardiac surgery. Methods Fifty-three dialysis-dependent patients (34 males, aged 67 ± ...
    • Can We Refuse Revascularization in Current Smokers Suffering from Chronic Limb Threatening Ischemia? 

      Kouvelos G.N., Spanos K., Giannoukas A.D., Mavroforou A. (2020)
      [No abstract available]
    • Full blood count and peripheral arterial disease severity and prognosis 

      Spanos K., Matsagkas M., Giannoukas A. (2017)
      [No abstract available]
    • Hybrid procedures for chronic lower limb ischemia: What determines the outcome? 

      Spanos K., Antoniou G.A., Saleptsis V., Athanasoulas A., Drakou A., Koutsias S., Giannoukas A.D. (2017)
      BACKGROUND: To report the long term outcome of hybrid (combined open and endovascular) procedures for the management of multisegmental chronic peripheral arterial disease. METHODS: A retrospective analysis from a single ...
    • Intracranial and systemic atherosclerosis in the NAVIGATE ESUS trial: Recurrent stroke risk and response to antithrombotic therapy 

      Ameriso S.F., Amarenco P., Pearce L.A., Perera K.S., Ntaios G., Lang W., Bereczki D., Uchiyama S., Kasner S.E., Yoon B.-W., Lavados P., Firstenfeld A., Mikulik R., Povedano G.P., Ferrari J., Mundl H., Berkowitz S.D., Connolly S.J., Hart R.G. (2020)
      Background: Non-stenotic intracranial and systemic atherosclerosis are associated with ischemic stroke. We report frequency and response to anticoagulant vs. antiplatelet prophylaxis of patients with embolic stroke of ...
    • Lipid-lowering treatment in peripheral artery disease 

      Katsiki N., Giannoukas A.D., Athyros V.G., Mikhailidis D.P. (2018)
      Peripheral artery disease (PAD) is characterized by increased cardiovascular (CV) risk, limb morbidity and all-cause mortality. According to the current guidelines (2016) of the American Heart Association/American College ...
    • New devices to cross chronic total occlusion in critical limb ischemia 

      Spanos K., Kouvelos G., Karathanos C., Xhepa S., Giannoukas A., Matsagkas M. (2016)
      Chronic total occlusions (CTos) represent a technically demanding subset of lesions, which in most cases require special endovascular methods, advanced operator skills, and utilization of sophisticated assisting devices ...
    • Real world data from a multi-centre study on the effects of cilostazol on pain symptoms and walking distance in patients with peripheral arterial disease 

      Katsiki N., Tentolouris N., Marakomichelakis G., Richter D., Giannoukas A., Koufaki P., Papanas N., Alexopoulos I., Anastasiadis F., Andreadis E., Andreopoulos G., Apostolidis D., Christodoulou I., Christopoulos I., Dalaberis E., Daliani H., Dimitriou G., Dimitsikoglou I., Dimoulis N., Doulgerakis D., Douloumpakas I., Drakopoulou E., Felekis T., Feloukas T., Florou S., Fragakis D., Fregidis T., Gakis P., Galanakis C., Giakoumis A., Giannes N., Galapis A., Gouveris I., Groutsis T., Grapsas V., Grigoropoulos P., Iordanidis T., Kazakos K., Kazantzi M., Kapernopoulos H., Kapetanios K., Karagianni E., Karakostas F., Karapiperis D., Karotsis A., Karsanidis A., Kasfikis F., Kourouklis S., Kourtis T., Kourtidou P., Koutsias S., Kotsogiannis S., Lampousakis I., Latsios P., Liouri I., Makrygiannis P., Matsouki W., Bakalakou K., Bakiris P., Balogianni M., Benis A., Beri V., Beroukas A., Moysidis K., Nanos E., Nikolaou A., Dubovina M., Oikonomidis N., Pangalos E., Panagoulias G., Papadopoulos S., Paraskevas G., Peroulis M., Petoumenos V., Petrogiannis S., Pournaras G., Pourou H., Prionidis M., Rigas A., Rigas S., Rigopoulos D., Sakellariou D., Sarafianos P., Svolis K., Seferou M., Sklirou V., Spais G., Stathopoulos C., Stavridou V., Stavrou I., Sfiniadakis I., Tatola V., Topalidis I., Trikkalinou A., Tsagarakis D., Tsarouchas P., Valkaniotis G., Varella M., Vasilakakou S., Vlachopoulou M., Vouzas A., Zafeiriou I., Zafeiris I., Zacharopoulou O., Zinelis D., CI-WIN Investigators (2022)
      Objective: to assess the effects of cilostazol on pain-free walking distance in PAD patients with IC at 3 and 6 months in a real world, prospective, observational study. We included 1015 PAD patients presenting with IC ...